Research PaperJournal of Pharmacology and PharmacotherapeuticsVol. 9 | Issue 2 | 2018 | pp. 86–91Open access
Frequency of Chemotherapy Medication Errors: A Systematic Review
- 1,
- 2,
- 3,
- 4,
- 5,
- 6*
- 1 Department of Finance, Hospital Corporation of America, Foster City, California.
- 2 Department of Pharmacology, Ras Al Khaimah College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, United Arab Emirates.
- 3 Public Health Research and Surveillance, Independent Epidemiology Contractor, Kaneohe, Hawaii.
- 4 Department of Acute and Critical Care, College of Nursing, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
- 5 Department of Pharmacology, Faculty of Pharmacy, AIMST University, 08100 Bedong, Kedah, Malaysia.
- 6 Department of Pediatrics, CANSEARCH Research Laboratory, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Chakradhara Rao S. Uppugunduri
Department of Pediatrics, CANSEARCH Research Laboratory, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland.
Email: Chakradhara.Uppugunduri@unige.ch
Copyright: © 2018 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2018
- Received:
- May 8, 2018
- Accepted:
- Jul 14, 2018
How to cite
Ashokkumar, R., Srinivasamurthy, S., Kelly, J. J., Howard, S. C., Parasuraman, S., & Uppugunduri, C. R. S. (2018). Frequency of Chemotherapy Medication Errors: A Systematic Review. Journal of Pharmacology and Pharmacotherapeutics, 9(2), 86–91. https://doi.org/10.4103/jpp.JPP_61_18
Abstract
Objective: To synthesize peer‑reviewed knowledge on the frequency of different types of chemotherapy medication errors. Methods: The data were collected from studies published between January 1, 2000, and March 3, 2018, and are identified through online resources such as Medline/PubMed, PubMed Central, Agency for Healthcare Research, and Quality and the Cochrane Library. The manuscripts published in peer‑reviewed scientific journals in English language were included in the study. Initially, 19,723 articles were retrieved and finally 11 were found to be eligible to include in the review and were assessed for quality. Error percentages were calculated from the ratio of error type (numerator) to sample size (denominator: medication orders or prescriptions). Results: Overall, the chemotherapy medication errors ranged from 0.004% to 41.6% among various studies. Chemotherapy medication errors ranged from 0.1% to 24.6% in prescribing, 0.40% to 0.50% in preparation, 0.03% in dispensing, and 0.02% to 0.10% in administering phases. Conclusion: Prescribing phase had the highest number of chemotherapy medication errors reported, and least was reported during dispensing phase. We also noticed a need for harmonization for reporting of medication errors.
Keywords
Subject
Article metadata
| Title | Frequency of Chemotherapy Medication Errors: A Systematic Review |
|---|---|
| Authors | Ramkumar Ashokkumar; Sureshkumar Srinivasamurthy; Janet J. Kelly; Scott C. Howard; Subramani Parasuraman; Chakradhara Rao S. Uppugunduri |
| Affiliations | Department of Finance, Hospital Corporation of America, Foster City, California.; Department of Pharmacology, Ras Al Khaimah College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, United Arab Emirates.; Public Health Research and Surveillance, Independent Epidemiology Contractor, Kaneohe, Hawaii.; Department of Acute and Critical Care, College of Nursing, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.; Department of Pharmacology, Faculty of Pharmacy, AIMST University, 08100 Bedong, Kedah, Malaysia.; Department of Pediatrics, CANSEARCH Research Laboratory, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland. |
| Corresponding author | Chakradhara.Uppugunduri@unige.ch |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 9, Issue 2 (2018) |
Also in this issue
- Supplementary Protection Certificates are Detrimental to Medicine Affordabilitypp. 63–65
- Comprehensive Review on Methadone-Induced QT Prolongation and Torsadespp. 66–75
- Terlipressin-Induced Ischemic Complications: A Systematic Review of Published Case Reportspp. 76–85
- Investigation of hERG1b Influence on hERG Channel Pharmacology at Physiological Temperaturepp. 92–103
- Adverse Drug Reactions at an Addiction Psychiatry Center: A Cross‑sectional Analysispp. 104–108
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026